Immediate Impact

1 by Nobel laureates 1 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
2024 Standout
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
2022 Standout
2 intermediate papers

Works of Lindsay Potts being referenced

Efficacy and complications of adalimumab treatment for medically‐refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004–2008)
2008
The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
1998

Author Peers

Author Last Decade Papers Cites
Lindsay Potts 71 40 81 51 5 182
Fabio Del Zompo 66 42 119 50 10 289
Gérard Le Dréau 71 38 33 36 5 182
Hengameh Mirsepasi 63 36 62 55 8 264
Rosiane Lima 32 42 45 23 8 155
Anjelica Martin 39 24 60 34 4 267
Jason Bishai 58 10 114 22 8 295
Hailey L. Erkkila 27 17 45 39 5 229
James L. Richards 27 17 35 31 5 242
Keiran H McLeod 26 18 38 31 4 232
Jason Sniffen 32 30 121 102 10 289

All Works

Loading papers...

Rankless by CCL
2026